The Journal of Cell Biology, Vol 105, 2409-2415, Copyright © 1987 by The Rockefeller University Press

ARTICLES

Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains

G Taraboletti, DD Roberts and LA Liotta
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892.

Thrombospondin induces the migration of human melanoma and carcinoma cells. Using a modified Boyden chamber assay, tumor cells migrated to a gradient of soluble thrombospondin (chemotaxis). Checkerboard analysis indicated that directional migration was induced 27-fold greater than stimulation of random motility. Tumor cells also migrated in a dose- dependent manner to a gradient of substratum-bound thrombospondin (haptotaxis). A series of human melanoma and carcinoma cells were compared for their relative motility stimulation by thrombospondin haptotaxis vs. chemotaxis. Some cell lines exhibited a stronger haptotactic response compared to their chemotactic response while other lines exhibited little or no migration response to thrombospondin. Human A2058 melanoma cells which exhibit a strong haptotactic and chemotactic response to thrombospondin were used to study the structural domains of thrombospondin required for the response. Monoclonal antibody C6.7, which binds to the COOH-terminal region of thrombospondin, inhibited haptotaxis in a dose-dependent optimal manner. C6.7 had no significant effect on thrombospondin chemotaxis. In contrast, monoclonal antibody A2.5, heparin, and fucoidan, which bind to the NH2-terminal heparin-binding domain of thrombospondin, inhibited thrombospondin chemotaxis but not haptotaxis. Monoclonal antibody A6.1 directed against the internal core region of thrombospondin had no significant effect on haptotaxis or chemotaxis. Synthetic peptides GRGDS (50 micrograms/ml), but not GRGES, blocked tumor cell haptotaxis on fibronectin, but had minimal effect on thrombospondin or laminin haptotaxis. The 140-kD fragment of thrombospondin lacking the heparin- binding amino-terminal region retained the property to fully mediate haptotaxis but not chemotaxis. When the COOH region of the 140-kD fragment, containing the C6.7-binding site, was cleaved off, the resulting 120-kD fragment (which retains the RGDA sequence) failed to induce haptotaxis. Separate structural domains of thrombospondin are therefore required for tumor cell haptotaxis vs. chemotaxis. This may have implications during hematogenous cancer metastases formation.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Liu, A., Garg, P., Yang, S., Gong, P., Pallero, M. A., Annis, D. S., Liu, Y., Passaniti, A., Mann, D., Mosher, D. F., Murphy-Ullrich, J. E., Goldblum, S. E. (2009). Epidermal Growth Factor-like Repeats of Thrombospondins Activate Phospholipase C{gamma} and Increase Epithelial Cell Migration through Indirect Epidermal Growth Factor Receptor Activation. J. Biol. Chem. 284: 6389-6402 [Abstract] [Full Text]  
• Arguello, M., Paz, S., Hernandez, E., Corriveau-Bourque, C., Fawaz, L. M., Hiscott, J., Lin, R. (2006). Leukotriene A4 Hydrolase Expression in PEL Cells Is Regulated at the Transcriptional Level and Leads to Increased Leukotriene B4 Production.. J. Immunol. 176: 7051-7061 [Abstract] [Full Text]  
• Geho, D. H., Bandle, R. W., Clair, T., Liotta, L. A. (2005). Physiological Mechanisms of Tumor-Cell Invasion and Migration. Physiology 20: 194-200 [Abstract] [Full Text]  
• Margosio, B., Marchetti, D., Vergani, V., Giavazzi, R., Rusnati, M., Presta, M., Taraboletti, G. (2003). Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2. Blood 102: 4399-4406 [Abstract] [Full Text]  
• Orr, A. W., Elzie, C. A., Kucik, D. F., Murphy-Ullrich, J. E. (2003). Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J. Cell Sci. 116: 2917-2927 [Abstract] [Full Text]  
• Palmieri, D., Lee, J. W., Juliano, R. L., Church, F. C. (2002). Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer Cells. J. Biol. Chem. 277: 40950-40957 [Abstract] [Full Text]  
• Twal, W. O., Czirok, A., Hegedus, B., Knaak, C., Chintalapudi, M. R., Okagawa, H., Sugi, Y., Argraves, W. S. (2002). Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J. Cell Sci. 114: 4587-4598 [Abstract] [Full Text]  
• Lawler, J., Miao, W.-M., Duquette, M., Bouck, N., Bronson, R. T., Hynes, R. O. (2001). Thrombospondin-1 Gene Expression Affects Survival and Tumor Spectrum of p53-Deficient Mice. Am. J. Pathol. 159: 1949-1956 [Abstract] [Full Text]  
• Li, Z., He, L., Wilson, K. E., Roberts, D. D. (2001). Thrombospondin-1 Inhibits TCR-Mediated T Lymphocyte Early Activation. J. Immunol. 166: 2427-2436 [Abstract] [Full Text]  
• Goldblum, S. E., Young, B. A., Wang, P., Murphy-Ullrich, J. E. (1999). Thrombospondin-1 Induces Tyrosine Phosphorylation of Adherens Junction Proteins and Regulates an Endothelial Paracellular Pathway. Mol. Biol. Cell 10: 1537-1551 [Abstract] [Full Text]  
• Cox, G, Steward, W P, O'Byrne, K J (1999). The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax 54: 169-179 [Full Text]  
• Chen, H., Strickland, D. K., Mosher, D. F. (1996). Metabolism of Thrombospondin 2. BINDING AND DEGRADATION BY 3T3 CELLS AND GLYCOSAMINOGLYCAN-VARIANT CHINESE HAMSTER OVARY CELLS. J. Biol. Chem. 271: 15993-15999 [Abstract] [Full Text]  
• Adams, J. (1995). Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: implications for the anti-adhesive activities of thrombospondin-1. J. Cell Sci. 108: 1977-1990 [Abstract]  
• Adams, J., Lawler, J (1993). Diverse mechanisms for cell attachment to platelet thrombospondin. J. Cell Sci. 104: 1061-1071 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents